Clamoxyl Ready-To-Use 150 mg/ml Suspension for Injection

País: Regne Unit

Idioma: anglès

Font: VMD (Veterinary Medicines Directorate)

ingredients actius:

Amoxicillin

Disponible des:

Zoetis UK Limited

Codi ATC:

QJ01CA04

Designació comuna internacional (DCI):

Amoxicillin

formulario farmacéutico:

Suspension for injection

tipo de receta:

POM-V - Prescription Only Medicine – Veterinarian

Grupo terapéutico:

Cats, Cattle, Dogs, Pigs, Sheep

Área terapéutica:

Antimicrobial

Estat d'Autorització:

Authorized

Data d'autorització:

1990-12-03

Fitxa tècnica

Revised: April 2022
AN: 01524/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Clamoxyl Ready-To-Use 150 mg/ml suspension for injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE
MG/ML
Amoxicillin
150
(As Amoxicillin trihydrate)
For a full list of excipients please see section 6.1
3.
PHARMACEUTICAL FORM
Suspension for injection
A white to off white oily suspension
4.
CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs, cats, sheep, pigs and cattle
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infections caused by susceptible organisms in
dogs,
cats, sheep, pigs and cattle. The product is not effective against
beta-
lactamase producing organisms.
4.3 CONTRAINDICATIONS
Not to be used in rabbits, guinea pigs, hamsters or gerbils.
The suspension is not suitable for intravenous or intrathecal
administration.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product is not effective against beta-lactamase producing
organisms.
Complete cross-resistance has been shown between amoxicillin and
other penicillins, in particular amino-penicillins.
Use of the product/amoxicillin should be carefully considered when
antimicrobial susceptibility testing has shown resistance to
penicillins
because its effectiveness may be reduced.
Revised: April 2022
AN: 01524/2021
Page 2 of 5
4.5 SPECIAL PRECAUTIONS FOR USE
i)
Special precautions for use in animals
Do not use in animals with known sensitivity to the active
substance.
Use of the product should be based on susceptibility testing of
the bacteria isolated from the animal. If this is not possible,
therapy should be based on local epidemiological information.
This product does not contain an antimicrobial preservative.
ii)
Special precautions to be taken by the person administering
the veterinary medicinal product to animals
Care should be taken to avoid accidental self injection.
Penicillins
and
cephalosporins
may
cause
hypersensitivity
(allergy)
following
injection,
inhalation,
ingestion
or
skin
co